Sous couvert de faire du continent un leader mondial des « sciences de la vie », la Commission européenne confirme sa vision ...

En 2024, l’Union européenne a de nouveau enregistré des alertes de contamination par des OGM. Au nombre de 24, ces alertes ...

As the trialogue on the proposed deregulation of GMOs got underway on 6 May between the European Commission, the European Parliament and the Council of Member States of the European Union, French ...

Toulouse-based Micropep Technologies has just had one of its fungicidal micropeptides approved in the United States. The technology, developed and patented by this CNRS spin-off, is aiming for ...

In 2023, German and Spanish customs notified the presence of transgenic rice on their territory. This GM rice is not allowed for importation into Europe. Commercial cultivation is currently very ...

Many patents in the field of “life sciences” contain fictitious examples, known as “prophetic”, of how the invention can be realised. Such imaginary examples enable applicants to increase the scope of ...

In Norway, the Institute of Marine Research (IMR) i has filed a trial application, in 2023, for genetically modified salmon (VIRGIN® salmon). These salmon, bred in cages in the open sea, would be ...

Mosquitoes carry pathogens that cause diseases such as malaria and dengue fever, and are therefore known as vector-borne diseases. As part of the fight against these mosquitoes, researchers at ...

Eight years after its first releases of transgenic mosquitoes in Panama, Oxitec is planning a new phase of studies in the country, in partnership with Panama’s Institute for Scientific Research and ...

For the past fifteen years, governments have been discussing “synthetic biology” on an international level. If to date, an “operational” definition exists, the outlines of this field remain hard to ...

Les principaux droits de propriété industrielle utilisés dans le domaine du vivant sont le certificat d’obtention végétale (COV) et le brevet. Mais quelles sont les différences entre ces deux ...

The European Commission’s postponement of its “ biotech law ” until the end of 2026 is raising questions. Presented as a future “ regulation “, this law must be coordinated with other legal acts still ...